GN Store Nord A/S (CPH:GN)
107.60
+0.95 (0.89%)
Dec 17, 2025, 9:20 AM CET
GN Store Nord Market Cap
GN Store Nord has a market cap or net worth of 15.53 billion as of December 16, 2025. Its market cap has decreased by -18.68% in one year.
Market Cap
15.53B
Enterprise Value
25.76B
Revenue
17.12B
Ranking
n/a
PE Ratio
22.98
Stock Price
107.60
Market Cap Chart
Since March 30, 1993, GN Store Nord's market cap has increased from 330.14M to 15.53B, an increase of 4,603.87%. That is a compound annual growth rate of 12.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 15, 2025 | 15.81B | -18.80% |
| Dec 30, 2024 | 19.48B | -22.12% |
| Dec 29, 2023 | 25.01B | 22.33% |
| Dec 30, 2022 | 20.44B | -61.08% |
| Dec 30, 2021 | 52.52B | -16.31% |
| Dec 30, 2020 | 62.76B | 55.31% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.43T |
| Coloplast | 127.11B |
| Genmab | 124.12B |
| ALK-Abelló | 49.55B |
| Demant | 46.39B |
| H. Lundbeck | 41.34B |
| Zealand Pharma | 34.64B |
| Ambu A/S | 23.15B |